Target intelligence / Profile preview

MSC-Treg direct contact

Molecular classification
Other
01

Overview

Direct contact between mesenchymal stromal (or stem) cells (MSC) and regulatory T cells (Treg) refers to the physical interaction between these two cell types, which contributes significantly to their immunoregulatory effects. MSCs can induce Treg expansion and enhance their suppressive function through mechanisms that require cell-cell contact, as well as via soluble factors such as TGF-β and PGE2[1][2][4][5][7]. Specific surface molecules, including CD80 on MSCs (interacting possibly with CD28/CTLA-4 on Tregs) and CD43 on T cells (interacting with ICAM-1 on MSCs), have been implicated in mediating these interactions[3][4][7]. This crosstalk plays a key role in dampening immune responses in settings like autoimmunity, transplantation, and inflammation, but "MSC-Treg direct contact" itself does not represent a single defined protein or receptor target suitable for drugs in the conventional sense[1][2][5][7]. Key mechanistic details from the literature: - Direct contact is required for optimal induction of Treg phenotype and function by MSCs; separation by a membrane abrogates the effect[1][4][5][7]. - Surface molecules like CD80 (on MSCs) and CD43 (on T cells) are critical in this contact-dependent immunoregulation[3][4][7]. - Contact can result in transfer of cell components such as mitochondria and plasma membrane fragments from MSCs to Tregs[2]. - The interaction amplifies immunosuppressive functions and is a topic of interest for cell therapy, autoimmunity, and transplantation research[1][2][5]. This entry should be flagged as not a discrete target suitable for structured molecular information; instead, consider identifying the specific interacting molecules (e.g., CD80, ICAM-1, CD43) involved if further drug target analysis is desired.

Other names
Mesenchymal stem/stromal cell and regulatory T cell direct contactMSC-Treg interactionDirect MSC-Treg contact
02

Biological functions

Immune responseImmunomodulationCell-cell signaling
03

Disease associations

InflammationAutoimmune diseaseTransplant rejectionOther

Beyond the preview

Go deeper on MSC-Treg direct contact.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MSC-Treg direct contact.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call